Neuroprotection by astrocytes in brain ischemia: Importance of microRNAs

Neuroscience Letters

Volumn 565, Issue , 2014, Pages 53-58

  Ouyang, Yi Bing ^a   Xu, Lijun ^a   Yue, Sibiao ^b   Liu, Siwei ^a   Giffard, Rona G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Astrocyte; Cerebral ischemia; MicroRNA; MiR 146a; MiR 181; MiR 29

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 181; MICRORNA 181A; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ASTROCYTE; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL DEATH; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET CELL;

ASTROCYTE; CEREBRAL ISCHEMIA; MICRORNA; MIR-146A; MIR-181; MIR-29;

ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CELL SURVIVAL; GENETIC THERAPY; HUMANS; MICRORNAS; NEURONS;

EID: 84897049671     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.11.015     Document Type: Review

References (67)

1. Adams J.M., Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 2007, 19:488-496.
2. Aronica E., Fluiter K., Iyer A., Zurolo E., Vreijling J., van Vliet E.A., Baayen J.C., Gorter J.A. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2010, 31:1100-1107.
3. Barreto G., White R.E., Ouyang Y., Xu L., Giffard R.G. Astrocytes: targets for neuroprotection in stroke. Cent. Nerv. Syst. Agents Med. Chem. 2011, 11:164-173.
4. Bernard S.A., Gray T.W., Buist M.D., Jones B.M., Silvester W., Gutteridge G., Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N. Engl. J. Med. 2002, 346:557-563.
5. Blakeley J.O., Llinas R.H. Thrombolytic therapy for acute ischemic stroke. J. Neurol. Sci. 2007, 261:55-62.
6. Boldin M.P., Baltimore D. MicroRNAs, new effectors and regulators of NF-kappaB. Immunol. Rev. 2012, 246:205-220.
7. Chassin C., Hempel C., Stockinger S., Dupont A., Kubler J.F., Wedemeyer J., Vandewalle A., Hornef M.W. MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury. EMBO Mol. Med. 2012, 4:1308-1319.
8. Chen C.Z. An unsolved mystery: the target-recognizing RNA species of microRNA genes. Biochimie 2013, 95:1663-1676.
9. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
10. Chen G., Zhu W., Shi D., Lv L., Zhang C., Liu P., Hu W. MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol. Rep. 2010, 23:997-1003.
11. Chen Q., Kong L., Xu X., Geng Q., Tang W., Jiang W. Down-regulation of microRNA-146a in the early stage of liver ischemia-reperfusion injury. Transplant. Proc. 2013, 45:492-496.
12. Clarke L.E., Barres B.A. Emerging roles of astrocytes in neural circuit development. Nat. Rev. Neurosci. 2013, 14:311-321.
13. Cui J.G., Li Y.Y., Zhao Y., Bhattacharjee S., Lukiw W.J. Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J. Biol. Chem. 2010, 285:38951-38960.
14. Dharap A., Bowen K., Place R., Li L.C., Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J. Cereb. Blood Flow Metab. 2009, 29:675-687.
15. Eacker S.M., Dawson T.M., Dawson V.L. The interplay of microRNA and neuronal activity in health and disease. Front. Cell. Neurosci. 2013, 7.
16. Ferrer I., Planas A.M. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J. Neuropathol. Exp. Neurol. 2003, 62:329-339.
17. Fragoso R., Mao T., Wang S., Schaffert S., Gong X., Yue S., Luong R., Min H., Yashiro-Ohtani Y., Davis M., Pear W., Chen C.Z. Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1. PLoS Genet. 2012, 8:e1002855.
18. Gebeshuber C.A., Zatloukal K., Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009, 10:400-405.
19. Giordano G., Kavanagh T.J., Costa L.G. Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71. Neurotoxicology 2009, 30:326-329.
20. Han Y.C., Park C.Y., Bhagat G., Zhang J., Wang Y., Fan J.B., Liu M., Zou Y., Weissman I.L., Gu H. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J. Exp. Med. 2010, 207:475-489.
21. Hebert S.S., Horre K., Nicolai L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6415-6420.
22. Hutchison E.R., Kawamoto E.M., Taub D.D., Lal A., Abdelmohsen K., Zhang Y., Wood W.H., Lehrmann E., Camandola S., Becker K.G., Gorospe M., Mattson M.P. Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia 2013, 61:1018-1028.
23. Iyer A., Zurolo E., Prabowo A., Fluiter K., Spliet W.G., van Rijen P.C., Gorter J.A., Aronica E. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS ONE 2012, 7:e44789.
24. Jeon Y.J., Kim O.J., Kim S.Y., Oh S.H., Oh D., Kim O.J., Shin B.S., Kim N.K. Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk. Arterioscler. Thromb. Vasc. Biol. 2013, 33:420-430.
25. Jeyaseelan K., Lim K.Y., Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008, 39:959-966.
26. 12 cells. PLoS ONE 2013, 8:e69351.
27. Jovicic A., Roshan R., Moisoi N., Pradervand S., Moser R., Pillai B., Luthi-Carter R. Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J. Neurosci. 2013, 33:5127-5137.
28. Khanna S., Rink C., Ghoorkhanian R., Gnyawali S., Heigel M., Wijesinghe D.S., Chalfant C.E., Chan Y.C., Banerjee J., Huang Y., Roy S., Sen C.K. Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. J. Cereb. Blood Flow Metab. 2013, 33:1197-1206.
29. Kole A.J., Swahari V., Hammond S.M., Deshmukh M. miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev. 2011, 25:125-130.
30. Krichevsky A.M., Sonntag K.C., Isacson O., Kosik K.S. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 2006, 24:857-864.
31. Liu D., Smith C.L., Barone F.C., Ellison J.A., Lysko P.G., Li K., Simpson I.A. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Brain Res. Mol. Brain Res. 1999, 68:29-41.
32. Liu D.Z., Tian Y., Ander B.P., Xu H., Stamova B.S., Zhan X., Turner R.J., Jickling G., Sharp F.R. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 2010, 30:92-101.
33. May L.A., Kramarenko I.I., Brandon C.S., Voelkel-Johnson C., Roy S., Truong K., Francis S.P., Monzack E.L., Lee F.-S., Cunningham L.L. Inner ear supporting cells protect hair cells by secreting HSP70. J. Clin. Invest. 2013, 123:3577-3587.
34. Miao Y., Qiu Y., Lin Y., Miao Z., Zhang J., Lu X. Protection by pyruvate against glutamate neurotoxicity is mediated by astrocytes through a glutathione-dependent mechanism. Mol. Biol. Rep. 2011, 38:3235-3242.
35. Miska E.A., Alvarez-Saavedra E., Townsend M., Yoshii A., Sestan N., Rakic P., Constantine-Paton M., Horvitz H.R. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004, 5:R68.
36. Moon J.M., Xu L., Giffard R.G. Inhibition of microRNA-181 reduces forebrain ischemia induced neuronal loss. J. Cereb. Blood Flow Metab. 2013, (in press).
37. 1 receptor-mediated pathways in astrocytes. PLoS ONE 2013, 8:e57898.
38. Ouyang Y.B. Inflammation and stroke. Neurosci. Lett. 2013, 548:1-3.
39. Ouyang Y.B., Giffard R.G. ER-mitochondria crosstalk during cerebral ischemia: molecular chaperones and ER-mitochondrial calcium transfer. Int. J. Cell Biol. 2012, 2012:493934.
40. Ouyang Y.B., Giffard R.G. MicroRNAs regulate the chaperone network in cerebral ischemia. Transl. Stroke Res. 2013, 1-11.
41. Ouyang Y.B., Lu Y., Yue S., Giffard R.G. miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 2012, 12:213-219.
42. Ouyang Y.B., Lu Y., Yue S., Xu L.J., Xiong X.X., White R.E., Sun X., Giffard R.G. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol. Dis. 2012, 45:555-563.
43. Ouyang Y.B., Stary C.M., White R.E., Voloboueva L.A., Giffard R.G. The use of microRNAs to modulate redox and immune response to stroke. Antioxid. Redox Signal. 2013, in press.
44. Ouyang Y.B., Stary C.M., Yang G.Y., Giffard R. microRNAs: innovative targets for cerebral ischemia and stroke. Curr. Drug Targets 2013, 14:90-101.
45. Ouyang Y.B., Voloboueva L.A., Xu L.J., Giffard R.G. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J. Neurosci. 2007, 27:4253-4260.
46. Ouyang Y.B., Xu L., Lu Y., Sun X., Yue S., Xiong X.X., Giffard R.G. Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia. Glia 2013, 61 (Nov11):1784-1794. 10.1002/glia.22556.
47. Pekarsky Y., Croce C.M. Is miR-29 an oncogene or tumor suppressor in CLL?. Oncotarget 2010, 1:224-227.
48. Pekarsky Y., Santanam U., Cimmino A., Palamarchuk A., Efanov A., Maximov V., Volinia S., Alder H., Liu C.G., Rassenti L., Calin G.A., Hagan J.P., Kipps T., Croce C.M. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006, 66:11590-11593.
49. Qu W.S., Wang Y.H., Wang J.P., Tang Y.X., Zhang Q., Tian D.S., Yu Z.Y., Xie M.J., Wang W. Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia. Neurochem. Res. 2010, 35:1716-1724.
50. Rathinam M.L., Watts L.T., Narasimhan M., Riar A.K., Mahimainathan L., Henderson G.I. Astrocyte mediated protection of fetal cerebral cortical neurons from rotenone and paraquat. Environ. Toxicol. Pharmacol. 2012, 33:353-360.
51. Shi G., Liu Y., Liu T., Yan W., Liu X., Wang Y., Shi J., Jia L. Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury. Exp. Brain Res. 2012, 216:225-230.
52. Shi L., Cheng Z., Zhang J., Li R., Zhao P., Fu Z., You Y. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008, 1236:185-193.
53. Smirnova L., Grafe A., Seiler A., Schumacher S., Nitsch R., Wulczyn F.G. Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 2005, 21:1469-1477.
54. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
55. Tan K.S., Armugam A., Sepramaniam S., Lim K.Y., Setyowati K.D., Wang C.W., Jeyaseelan K. Expression profile of microRNAs in young stroke patients. PLoS ONE 2009, 4:e7689.
56. THACAS Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N. Engl J. Med. 2002, 346:549-556.
57. Wang H., Garzon R., Sun H., Ladner K.J., Singh R., Dahlman J., Cheng A., Hall B.M., Qualman S.J., Chandler D.S., Croce C.M., Guttridge D.C. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008, 14:369-381.
58. Wang X., Ha T., Liu L., Zou J., Zhang X., Kalbfleisch J., Gao X., Williams D., Li C. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc. Res. 2013, 97:432-442.
59. Weller M.L., Stone I.M., Goss A., Rau T., Rova C., Poulsen D.J. Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia. Neuroscience 2008, 155:1204-1211.
60. Wu X., Zhou C., Du F., Lu Y., Peng B., Chen L., Zhu L. Ginkgolide B preconditioning on astrocytes promotes neuronal survival in ischemic injury via up-regulating erythropoietin secretion. Neurochem. Int. 2013, 62:157-164.
61. 2 reduces neuronal vulnerability to forebrain ischemia. Glia 2010, 58:1042-1049.
62. Ye Y., Perez-Polo J.R., Qian J., Birnbaum Y. The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol. Genomics 2011, 43:534-542.
63. Yin K.J., Deng Z., Huang H., Hamblin M., Xie C., Zhang J., Chen Y.E. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis. 2010, 38:17-26.
64. Yuan Y., Wang J.Y., Xu L.Y., Cai R., Chen Z., Luo B.Y. MicroRNA expression changes in the hippocampi of rats subjected to global ischemia. J. Clin. Neurosci. 2010, 17:774-778.
65. Zhang L., Chopp M., Liu X., Teng H., Tang T., Kassis H., Zhang Z.G. Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1856-1864.
66. Zhao Y., Rempe D. Targeting astrocytes for stroke therapy. Neurotherapeutics 2010, 7:439-451.
67. 1R-initiated, IP3R-dependent stimulation of astrocyte mitochondrial metabolism reduces and partially reverses ischemic neuronal damage in mouse. J. Cereb. Blood Flow Metab. 2013, 33:600-611.